KLF12 and neoplasm: KLF12 was originally discovered as a suppressor of the transcription factor AP‐2α, which is mainly expressed in tissues such as the brain, kidney, liver, and lung [2, 4] Recently, various studies have indicated that KLF12 is involved in tumor progression.